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Abstract Serotonin neurons arise from the brainstem
raphe nuclei and send their projections throughout the brain
to release 5-HT which acts as a modulator of several
neuronal populations. Previous electron microscopy studies
in rats have morphologically determined the distribution of
5-HT release sites (boutons) in certain brain regions and
have shown that 5-HT containing boutons form synaptic
contacts that are either symmetric or asymmetric. In
addition, 5-HT boutons can form synaptic triads with the
pre- and postsynaptic specializations of either symmetrical
or asymmetrical synapses. However, due to the labor
intensive processing of serial sections required by electron
microscopy, little is known about the neurochemical
properties or the quantitative distribution of 5-HT triads
within whole brain or discrete subregions. Therefore, we
used a semi-automated approach that combines immuno-
histochemistry and high-resolution confocal microscopy to
label serotonin transporter (SERT) immunoreactive axons
and reconstruct in 3D their distribution within limbic brain
regions. We also used antibodies against key pre- (synap-
tophysin) and postsynaptic components of excitatory
(PSD95) or inhibitory (gephyrin) synapses to (1) identify
putative 5-HTergic boutons within SERT immunoreactive
axons and, (2) quantify their close apposition to
neurochemical excitatory or inhibitory synapses. We pro-
vide a 5-HTergic axon density map and have determined
the ratio of synaptic triads consisting of a 5-HT bouton in
close proximity to either neurochemical excitatory or
inhibitory synapses within different limbic brain areas. The
ability to model and map changes in 5-HTergic axonal
density and the formation of triadic connectivity within
whole brain regions using this rapid and quantitative
approach offers new possibilities for studying neuroplastic
changes in the 5-HTergic pathway.
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Introduction
Serotonin (5-hydroxytryptamine, 5-HT) is a neuromodu-
lator extensively implicated in the regulation of mood,
emotion, sleep and appetite. Furthermore, alterations in
5-HTergic neuronal signaling contribute to various neu-
ropsychiatric disorders such as anxiety, major depression
and drug abuse. Serotonin neurons arising from the brain-
stem raphe nuclei send their projections throughout the
brain to form direct synapses with the neuropil of the tar-
geted neurons. In addition, 5-HT is diffusely released by
‘‘volume transmission’’ (extra-synaptic) in several brain
regions and initiates neuromodulatory activity of excitatory
and inhibitory synapses in contrast to ‘‘classical’’ neuro-
transmitters (Bunin and Wightman 1998; De-Miguel and
Trueta 2005; Kiss 2008). In some cases, 5-HT neurons
contact glutamatergic or GABAergic/glycinergic synapses
to form synaptic triads that modulate the activity of exci-
tatory or inhibitory synapses (For review, see Ciranna
2006).
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The distribution of 5-HT release sites along the varicose
axons (boutons) in the brain has primarily and extensively
been determined from electron microscopy studies in rats
(for review, see Descarries et al. 2010). Furthermore,
immunocytochemistry and autoradiography studies have
shown that two distinct morphological types of 5-HTergic
varicose axons densely innervate all brain regions and
make both symmetrical (excitatory) and asymmetrical
(inhibitory) synapses with variable synaptic incidences (for
review, see Descarries et al. 2010). These studies have also
revealed a variable distribution of 5-HTergic contact types
(i.e., symmetric, asymmetric or undefined) throughout the
brain, suggesting that the excitatory/inhibitory balance of
5-HTergic innervation is finely tuned in discrete regions.
While both excitatory and inhibitory synaptic triads have
also been demonstrated in these studies, the labor intensive
batch processing of serial sections and multistep
immunolabeling required to identify neurochemical mark-
ers from electron microscopy sections makes their quanti-
tative distribution throughout the brain poorly understood.
Furthermore, species differences (rat, monkey, cat, and
guinea pig) and the use of different labeling techniques and
markers for 5-HTergic axons [antibodies directed against
5-HT, the serotonin transporter (SERT), the synthesis
enzyme tryptophan hydroxylase 2 (TPH2), or radiolabeling
with [3H] 5-HT] have made differences in 5-HT axonal
distribution and 5-HTergic triadic connectivity difficult to
interpret.
Recently, improved automated or semi-automated
techniques have been developed for in vitro and in vivo
quantification of synapses using fluorescence microscopy
(Ippolito and Eroglu 2010; Scha¨tzle et al. 2012; Dumitriu
et al. 2012; Busse and Smith 2013; Fogarty et al. 2013;
Danielson and Lee 2014; Sanders et al. 2015; Klenowski
et al. 2015; Sigal et al. 2015). The combination of fluo-
rescence microscopy, immunolabeling of key pre- and
postsynaptic markers of excitatory/inhibitory synapses and
automated software analysis, has afforded new high-
throughput methodology allowing for rapid quantification
of putative neurochemical synapses. Similar approaches
have also been used to characterize the architecture of
excitatory and inhibitory inputs onto TPH-positive neurons
in the dorsal raphe (DR) and identify GABA-glutamate
synaptic triads that may control excitatory transmission in
the DR (Soiza-Reilly et al. 2013; Soiza-Reilly and Com-
mons 2014).
Here, we have adapted a semi-automated method to
quantify the 3D distribution of serotonergic axons,
determine the number of putative serotonergic boutons,
and quantify those in close apposition to neurochemical
excitatory or inhibitory synapses in different regions and
subregions of the mouse limbic brain including the medial
prefrontal cortex (mPFC), the nucleus accumbens shell
(NACs) and core (NACc), bed nucleus of the stria ter-
minalis (BNST), the basolateral (BLA) and central (CeA)
amygdala, the hippocampus (HIP) and the ventral
tegmental area (VTA). We used an antibody against the
serotonin transporter SERT, which has been shown to be
a more robust marker of 5-HT axons than 5-HT itself
(Nielsen et al. 2006), to reconstruct 5-HTergic axons
using IMARIS software which allowed for volumetric
quantification of SERT-immunoreactive (SERT?) axon
fiber density in these brain regions. Concurrently, we
identified putative serotonergic presynaptic release sites
(boutons) within the SERT? axons and quantified
5-HTergic boutons in close apposition to neurochemical
excitatory and inhibitory synapses. We used well vali-
dated and commercially available antibodies to immuno-
label key pre- and postsynaptic specializations of
excitatory and inhibitory synapses. For SERT? boutons
and presynaptic endings of both excitatory (glutamate)
and inhibitory (GABA/glycine) terminals, we used an
antibody against synaptophysin (SYN), an abundant
synaptic vesicle membrane protein involved in synaptic
vesicle exocytosis (McMahon et al. 1996). For excitatory
postsynaptic specializations, we have used an antibody
against postsynaptic density 95 (PSD95), a scaffolding
protein that interacts with glutamate receptors and den-
dritic spine cytoskeletons in the postsynaptic membrane
of neurons (Sheng and Pak 2000; Sheng and Sala 2001).
For inhibitory postsynaptic specializations, we have used
an antibody against gephyrin (GEPH), a scaffolding pro-
tein that interacts with postsynaptic GABAergic and
glycinergic receptors (for review, see Tyagarajan and
Fritschy 2014). Confocal images were then acquired and
used to perform semi-automated spot analysis (Fogarty
et al. 2013; Klenowski et al. 2015) using Imaris 8.1.2
software. This involved isolating the SYN puncta within
SERT? axons (SYNSERT? boutons) that were located
within a distance of 0.6 lm to either the pre- or postsy-
naptic components of neurochemical excitatory (excita-
tory triads) or inhibitory synapses (inhibitory triads). This
allowed us to quantify and map the distribution of sero-
tonergic excitatory and inhibitory triads within the limbic
brain structures.
This work provides a robust and reproducible quantita-
tive method of rapidly screening the SERT? axonal density
and serotonergic triadic connectivity in the mouse brain.
The use of this methodology in the future studies could
help to uncover changes in 5-HT neuronal fiber density and
5-HT connectivity in animal models of neuropsychiatric
disorders and drug addiction.




Male C57BL/6J mice (n = 3, 5-week-old, ARC, WA,
Australia), were group-housed in ventilated Plexiglas cages
with ad libitum access to food and water in a climate-
controlled, 12-h light/dark cycle room (lights on at 9:00
am). Mice were given 1 week to acclimatize to the housing
conditions prior to the start of experiments. All procedures
were approved by the Queensland University of Technol-
ogy animal ethics committee and the University of
Queensland animal ethics committee.
Fixation and tissue processing
Animals were transcardially perfused with 4 %
paraformaldehyde in 0.1-M phosphate-buffered saline
solution (PBS), pH 7.4. Brains were dissected, removed
and postfixed overnight. They were then cryoprotected in
20 % sucrose in PBS for 24 h at 4 C followed by an
overnight incubation in 30 % sucrose in PBS at 4 C.
Brains were embedded in optimal cutting temperature
(OCT, Tissue-Tek, ProSciTech, Australia), snap frozen in a
dry ice isopentane slurry and kept at -80 C until pro-
cessing. Brains were serially sectioned (30 lm) in the
coronal plane using a cryostat (ThermoScientific
HM525NX) and kept as free-floating sections in ice-cold
PBS. Sections were rinsed 3 times in PBS to remove any
trace of OCT.
Antibodies and sera
Rabbit polyclonal anti-SERT antibody (PC177L) and
mouse monoclonal anti-synaptophysin antibody
(MAB5258) were purchased from Merck Millipore
(Bayswater, Australia). Mouse monoclonal anti-PSD95
antibody (6G6-1C9) and rabbit polyclonal anti-gephyrin
(Ab32206) antibody were purchased from Abcam (Mel-
bourne, Australia). Goat anti-rabbit-Alexa488, goat anti-
rabbit Alexa555, goat anti-mouse-Cy5, and goat anti-
mouse-Alexa405 antibodies were purchased from Life
Technologies (Mulgrave, Australia). Normal mouse
(NMS), normal rabbit (NRS), normal goat (NGS) sera, goat
F(ab) anti-mouse and anti-rabbit antibodies were purchased
from Abcam (Melbourne, Australia) (Table 1).
Immunohistochemistry
Specificity and optimal signal-to-noise ratios of each anti-
body were individually controlled by comparing the
labeling produced by incubation of the secondary anti-
bodies alone (Supp Fig. S1). Sequential immunohisto-
chemical staining was then performed in two stages as
follows: sections were first incubated at room temperature
for 1 h in blocking solution [4 % NGS, 1 % bovine serum
albumin (BSA), 0.3 % Triton and 0.05 % Tween20 in
PBS]. Sections were then incubated for 24 h at 4 C under
orbital agitation in a mix of rabbit anti-SERT (1/1000) and
mouse anti-PSD95 (1/1000) antibodies diluted in blocking
solution. After 3 9 10 min washes in blocking solution,
slices were incubated in a combination of goat anti-rabbit-
Alexa488 (1/1000) and goat anti-mouse-Cy5 (1/1000)
diluted in blocking solution for 4 h at room temperature.
Slices were then washed in blocking solution (3 9 10 min)
followed by PBS (3 9 10 min). To block the free binding
sites from the first labeling round, slices were incubated in
a mix of 5 % NMS and 10 % NRS diluted in blocking
solution, for 1 h at room temperature under orbital agita-
tion then rinsed 3 9 10 min in blocking solution. Slices
were then incubated in goat anti-mouse (1/100) and goat
anti-rabbit (1/100) monovalent F(ab) antibody fragments
diluted in PBS and agitated for 1 h at room temperature,
then washed 3 9 10 min in blocking solution. For the
second stage of the immunolabeling process, slices were
incubated in a combination of rabbit anti-gephyrin (1/1000)
and mouse anti-synaptophysin (1/500) diluted in blocking
solution for 24 h at 4 C under agitation. After three
washes in blocking solution, slices were incubated in a
mixture of goat anti-rabbit-Alexa455 (1/1000) and goat
Table 1 Antibodies used in this study
Antigen Host Immunogen Supplier Catalog # Dilution References
SERT Rabbit Synthetic peptide corresponding
to amino acids 602–622 of rat 5-HT transporter
Millipore PC177L 1/1000 Zhou et al. (1996)
Synaptophysin Mouse Vesicular fraction of bovine brain Millipore MAB5258 1/500 Tabuchi et al. (2007)
PSD95 Mouse Purified recombinant rat PSD-95 Abcam Ab2723 1/1000 Tomer et al. (2014)
Gephyrin Rabbit Synthetic peptide conjugated to
KLH derived from within
residues 700 to the C-terminus
of Mouse Gephyrin
Abcam Ab32206 1/1000 Nunez-Para et al. (2013)
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anti-mouse-Alexa405 (1/750) diluted in blocking solution
for 4 h at room temperature. Slices were then washed in
blocking solution (3 9 10 min) followed by PBS
(3 9 10 min) and mounted on slides with Prolong Gold
antifade mouting media (Life Technologies, Scoresby,
Australia).
Control of specificity for second stage
immunolabeling
To assess the specificity of the second round of primary
antibodies, control slices were processed under the same
conditions as above except that the second stage primary
antibodies (anti-gephyrin and anti-synaptophysin) were
omitted (Supp Fig. S2). To eliminate any bias in the
labeling sequence, we interchanged the sequence of pri-
mary antibodies as well as the secondary antibody used to
reveal each primary antibody.
Imaging
Confocal images (1024 9 1024) were acquired on an
Olympus FV1200 microscope fitted on a IX83 automated
inverted platform with a 609 oil-immersed objective (NA
1.35) equipped with solid state lasers (405, 488, 559, and
635 nm) at an exposure of 2 ls/pixel, a numerical zoom of
2.59 and a z-step of 0.3 lm. Sequential scanning of the
channels was used to avoid any overlapping in the emis-
sion/excitation wavelengths (488 ? 635 and
405 ? 541 nm). A total of 30 images at a z-depth of 20 lm
(0.3-lm step size, 65 z-stacks) were acquired for each brain
region. This combination yielded a pixel size of 82 lm
with a resolution limit of 150 lm according to Abbe’s law
(Wang and Smith 2012). To compensate for light scattering
and the point spread function, images were deconvolved
using Huygens Professional Software (SVI) with a maxi-
mum of 100 iterations, a quality threshold of 0.001 and a
signal-to-noise ratio (SNR) of 10. Deconvolved images
were saved as Imaris classic files to conserve the x/y/
z voxel size. Deconvolution using Huygens has been shown
to allow for the reconstruction of images with a resolution
of 50 nm (lateral)/100 nm (axial) (Schrader et al. 1996).
Image analysis using Imaris 8.1.2
Imaris analysis was performed as previously described
(Scha¨tzle et al. 2012; Fogarty et al. 2013; Klenowski et al.
2015). Briefly, SERT immunolabeled fibers were recon-
structed in 3D using the surface rendering function in
Imaris and the volumetric density was calculated. The
‘masking’ function was then used to remove intra-fiber
labeling and conserve the synaptophysin (Synout), PSD95
(PSD95out) and gephyrin (Gephout) punctuate fluorescence
located outside the created SERT-surface, which was used
to identify putative excitatory and inhibitory neurochemi-
cal synapses. In parallel, the removal of the synaptophysin
fluorescence signal outside of the SERT-surface ensured
that only intra-fiber synaptophysin labeling remained,
allowing for quantification of putative 5-HT synaptic
boutons (SYNSERT?). Then, the ‘spot detection’ function
was individually applied for each created mask (Synin:
5-HT bouton, Synout/PSD95out: excitatory synapse and
Synout/Gephout: inhibitory synapse) for detection of puncta
with a diameter of 0.4 lm and above. This size was
selected based on the z step-size to ensure that puncta were
present in a minimum of two confocal optical slices, as
previously described (Fogarty et al. 2013; Klenowski et al.
2015). Localization of Synout/PSD95out or Synout/Gephout
pairs within a distance of a 0.6 lm was performed using
the ‘spot colocalization’ ImarisXT plugin to identify the
appositions of pre- and postsynaptic markers as putative
excitatory or inhibitory synapses, respectively. Then,
SYNSERT? boutons that were located within 0.6 lm of
Synout/PSD95out (putative excitatory synapse) or Synout/
Gephout (putative inhibitory synapse) spots pairs identified
serotonergic excitatory and inhibitory triads, respectively.
Data were plotted in Graphpad Prism 6.0 software (La
Jolla, California, USA).
Statistical analysis
Thirty images from three animals were averaged to gen-
erate a group mean (n = 3) and SEM. Statistical signifi-
cance was assessed by one- or two-way ANOVA analysis
of variances with Bonferroni post hoc multiple compar-
isons. All numerical data are expressed as mean ± SEM
and significance was established at p\ 0.05. To determine
whether the proportion of putative excitatory/inhibitory
synapses contributed to the number excitatory/inhibitory
triads identified in each brain region, we performed Pear-
son correlation analysis on their respective ratios within the
brain areas analyzed.
Results
Previous electron microscopy studies suggest that 5-HT is
released from axonal varicosities that can be non-synaptic
in close or relatively distant apposition to other dendrites
and functions as ‘‘volume transmission’’ (Fig. 1a-1). In
addition, 5-HT axon terminals engaged in asymmetric
(Fig. 1a-2) or symmetric (Fig. 1a-3) synapses that directly
contact the dendrites or axons of target neurons have also
been observed. Studies have also shown that 5-HTergic
boutons may synapse to either the pre- or postsynaptic
components of GABA/glycinergic (Fig. 1a-4) or
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glutamatergic (Fig. 1a-5) synapses to form synaptic triads,
which could have a modulatory effect on these synapses.
By combining immunohistochemistry and 3D reconstruc-
tion, we mapped and quantified the distribution of putative
5-HT synaptic triads containing SYNSERT? boutons loca-
ted within 0.6 lm of neurochemical excitatory or inhibi-
tory synapses (Fig. 1a, red boxes) in different limbic brain
regions known to be densely innervated by 5-HTergic
fibers. Our analysis included layers I–III of the prelimbic
cortex (mPFC, bregma 2.1 ± 0.3 mm), the ventral nucleus
accumbens core and the medial shell (NACc and NACs,
bregma 1.18 ± 0.3 mm), the ventromedial and postero-
lateral part of the bed nucleus of the stria terminalis
(BNST, bregma 0.18 ± 0.2 mm), the basolateral and cen-
tral amygdala (BLA and CeA, bregma -1.46 ± 0.4 mm),
the strata oriens of the CA3 region of the hippocampus
(HIP, bregma -1.46 ± 0.4 mm) and the ventral tegmental
area (VTA, bregma -2.92 ± 0.2 mm) (Fig. 1b).
We used well-validated, commercially available anti-
bodies which are listed in Table 1, and the controls for
Fig. 1 Overview of serotonergic connectivity in limbic brain regions.
a Synaptic, extra-synaptic and triadic connectivity of 5-HT axons.
5-HT is released from varicosities of serotonergic axons both extra-
synaptically (1) and synaptically into asymmetrical (2) and symmet-
rical synapses (3). In addition, serotonin varicosities appose excita-
tory/glutamate or inhibitory/GABA/glycine synapses to form triads
consisting of a 5-HTergic bouton and the pre- and postsynaptic
components of an excitatory or inhibitory synapse (4, 5). In our study,
putative 5-HT boutons were defined by synaptophysin puncta located
inside the SERT immunoreactive axons (dark blue). Neurochemical
excitatory or inhibitory synapses were defined as spot pairs consisting
of the presynaptic marker synaptophysin puncta located outside of the
SERT immunoreactive fibres (light blue) that were within 0.6 lm of
the postsynaptic markers of excitatory (PSD95, purple) or inhibitory
(gephyrin, red) postsynaptic markers synapses (4, 5). Then, synaptic
5-HT triads were defined by putative 5-HT boutons in close
apposition to either the pre- or postsynaptic marker of putative
excitatory or inhibitory synapses (4, 5). b Coronal diagrams of limbic
brain regions selected for the study included layer I/III of the
prelimbic area of the medial prefrontal cortex (mPFC), the ventral
core and medial shell of the nucleus accumbens (NACc and NACs,
respectively), the ventromedial and posterolateral part of the bed
nucleus of the stria terminalis (BNST), the central and basolateral
amygdala (CeA and BLA, respectively), the strata oriens layer of the
CA3 region of the hippocampus (HIP), and the ventral tegmental area
(VTA). The coordinates corresponding to each brain region (top of
each diagram) are relative to bregma (mm)
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antibody specificity along the two-stage immunohisto-
chemistry protocol are provided in supplementary Figs. S1
and S2, respectively.
Distribution of SERT-immunoreactive axons
throughout the limbic brain
SERT-immunoreactive (SERT?) axons were reconstructed
in 3D throughout eight brain regions using the surface-
rendering tool of Imaris 8.1.2 software (Fig. 2a–j). We
subsequently quantified their volumetric density in each
limbic brain region here expressed as mm3 of fiber per cm3
of tissue (mm3/cm3) (Fig. 2k). We analyzed a total
195.43 mm of SERT? fibers across eight brain regions,
corresponding to a total volume of 821,456.07 lm3. We
found an average SERT? fiber density of 5.81 ±
0.34 mm3/cm3 in the mPFC, 14.33 ± 0.87 mm3/cm3 in the
NACs, 6.32 ± 0.53 mm3/cm3 in the NACc, 11.81 ±
0.89 mm3/cm3 in the BNST, 19.32 ± 0.71 mm3/cm3 in the
BLA, 7.12 ± 0.49 mm3/cm3 in the CeA, 10.24 ±
0.48 mm3/cm3 in the HIP and 54.54 ± 3.3 mm3/cm3 in the
VTA (Fig. 2k). The highest SERT? fiber density was found
in the VTA followed by BLA[NACs[ BNST[
HIP[CeA[NACc[mPFC (Supp Table 1 for statisti-
cal analysis).
From the volume and the lateral surface of the recon-
structed fibers obtained from Imaris software, we have
calculated an average diameter of SERT immunoreactive
axons throughout the sampled brain regions using the fol-
lowing formula: D ¼ 4V
A
, with D: diameter; A: lateral area
and V: volume. This calculation gives an estimated average
diameter taking the diameter of both the axon and the
boutons into account. We found that SERT? fibers have an
average diameter (mean ± SEM) of 0.645 ± 0.007 lm in
the mPFC, 0.689 ± 0.017 lm in the NACs,
0.687 ± 0.009 lm in the NACc, 0.652 ± 0.008 lm in the
BNST, 0.742 ± 0.006 lm in the BLA, 0.712 ± 0.004 lm
in the CeA, 0.715 ± 0.008 lm in the HIP and
0.793 ± 0.011 lm in the VTA (Fig. 2l). The highest
SERT? fiber diameter was found in the VTA[BLA[
HIP[CeA[NACs[NACc[BNST[mPFC (Supp
Table 2 for statistical analysis).
Distribution of putative presynaptic boutons
along SERT-positive axons (SYNSERT1)
To quantify the density of putative presynaptic boutons, we
used the masking function in Imaris software to remove the
labeling of the presynaptic marker synaptophysin (Synout)
that was located outside of the 3D-reconstructed SERT-
immunoreactive fibers surface (Fig. 3a–e). We then per-
formed a spot detection of the synaptophysin labeling
(Fig. 3c, f) located inside the 3D-reconstructed SERT?
fibers (SYNSERT?) (Fig. 3g) and determined the volumetric
density of SYNSERT? presynaptic boutons per lm3 of tis-
sue (Fig. 3h) or per lm3 of SERT-reconstructed fiber in
each brain region (Fig. 3i). The average density of
SynSERT? bouton per 103 lm3 of tissue was (mean ± -
SEM) 8.26 ± 0.83 in the mPFC, 17.00 ± 1.88 in the
NACs, 1.76 ± 0.24 in the NACc, 11.33 ± 1.65 in the
BNST, 18.90 ± 1.29 in the BLA, 7.80 ± 0.85 in the CeA,
6.88 ± 0.48 in the HIP and 98.39 ± 7.40 in the VTA
(Fig. 3h and Supp Table 3 for detailed statistical analysis),
which corresponds to a density per lm3 of SERT? fiber
(mean ± SEM) of 1.45 ± 0.14 in the mPFC, 1.18 ± 0.10
in the NACs, 0.26 ± 0.02 in the NACc, 0.90 ± 0.08 in the
BNST, 0.98 ± 0.05 in the BLA, 1.113 ± 0.06 in the CeA,
0.66 ± 0.03 in the HIP and 1.83 ± 0.09 in the VTA
(Fig. 3i and Supp Table 4 for statistical analysis).
Apposition of SYNSERT1 boutons to neurochemical
excitatory synapses (‘‘5-HT excitatory triads’’)
By combining confocal fluorescence microscopy with
Huygens deconvolution software, we generated high-reso-
lution images to determine SERT? boutons in close
proximity to neurochemical excitatory synapses (Fig. 4).
SERT? boutons (SYNSERT?, Fig. 4, blue ? green) were
defined within the SERT? varicosities (Fig. 4, green) using
the presynaptic marker synaptophysin (Fig. 4, blue).
Putative excitatory synapses (Fig. 4, blue ? purple) were
defined as spot pairs of PSD95 puncta (Fig. 4, purple)
located within 0.6 lm of synaptophysin puncta located
outside the SERT? fibers (Fig. 4, blue).
To 3D reconstruct and quantify the density of
SYNSERT? boutons apposed to neurochemical excitatory
synapses (Fig. 5a–g), we first masked the fluorescence
signals of the excitatory pre- and postsynaptic markers
located within the SERT? fibers. This isolated the fluo-
rescence signals of the excitatory pre- (Synout) and post-
synaptic markers (PSD95out) outside of the SERT? fibers.
Detection of Synout/PSD95out spot pairs within 0.6 lm
allowed for quantification of neurochemical excitatory
synapses in a manner similar to previous reports (Fogarty
et al. 2013; Klenowski et al. 2015) (Fig. 5a–d). Then, we
quantified the density of SYNSERT? boutons that were
located within 0.6 lm of the Synout/PSD95out spot pairs
and determined whether they were located closer to either
the presynaptic component (SYN) (Fig. 5e), the postsy-
naptic component (PSD95) (Fig. 5f) or both (equally dis-
tant) (Fig. 5g). The average density of excitatory triads
expressed per 103 lm3 SERT? fiber was (mean ? SEM)
340.70 ± 41.24 in the mPFC, 160.31 ± 11.09 in the
NACs, 51.29 ± 5.40 in the NACs, 93.41 ± 7.19 in the
1302 Brain Struct Funct (2017) 222:1297–1314
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BNST, 235.33 ± 23.06 in the BLA, 264.33 ± 19.97 in the
CeA, 145.33 ± 12.40 in the HIP and 1.28 ± 0.34 in the
VTA (Fig. 5g; Table 2 and Supp Table 5 for detailed sta-
tistical analysis). The majority of SYNSERT? boutons were
equidistant from the Synout and PSD95 markers (0.6 lm),
and no significant differences in pre- or postsynaptic
proximity were found in most of the brain regions ana-
lyzed. However, in the CeA, a higher proportion of
SYNSERT? boutons were located closer to the presynaptic
component of the putative excitatory synapses, as com-
pared with the postsynaptic component (CeA pre: 56 ± 6
vs CeA post: 28 ± 3 triads/103 lm3 of SERT? fiber,
***p = 0.0009, two-way ANOVA followed by Bonferroni
post hoc analysis) (Table 2 and Supp Table 6 for statistical
analysis).
Apposition of SYNSERT1 boutons to neurochemical
inhibitory synapses (‘‘5-HT inhibitory triads’’)
We also used the abovementioned method to determine the
density of SERT? boutons in close proximity to neuro-
chemical inhibitory synapses (Fig. 6). Similarly, putative
Fig. 2 Distribution of SERT
immunoreactive serotonergic
axons throughout the limbic
brain regions. a–
h Representative 60x
micrographs of SERT? axons in
the mPFC (a), NACs (b), NACc
(c), BNST (d), CeA (e), BLA
(f), HIP (g) and VTA (h). The
micrographs correspond to the
maximum intensity projection
of 50 z-stacks across a 15-lm z-
depth. i Higher magnification of
a SERT immunoreactive axon
in the BLA, and j shows the
corresponding 3D
reconstruction using Imaris
software. k Quantification of the
density of SERT
immunoreactive fibers
throughout the limbic brain. The
results, expressed in mm3 of
fibers per cm3 of tissue, are
represented as the
mean ± SEM of n = 30
images/brain region.
l Extrapolated average diameter
of SERT-immunoreactive fibers
in each brain region (see
‘‘Material and methods’’). The
results are expressed in lm and
represented as the
mean ± SEM of n = 30
images/brain region. Scale bars,
a–h 10 lm; i–j 5 lm
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SERT? boutons (SYNSERT?, Fig. 6, blue ? green) within
the SERT? varicosities (Fig. 6, green) were identified
using the presynaptic marker synaptophysin (Fig. 6, blue),
and putative inhibitory synapses (Fig. 6, blue ? red) were
identified as spot pairs of gephyrin (GEPH) puncta (Fig. 6,
red) closely apposed to synaptophysin puncta outside the
SERT? fibers (Fig. 6, blue).
We performed an identical spot analysis of the
SYNSERT? boutons in close proximity to neurochemical
inhibitory synapses by quantifying the Synout/Gephout spot
pairs (Fig. 7a–g). We found that the average density of
inhibitory triads per 103 lm3 of SERT? fibers was
(mean ? SEM) 43.77 ± 7.27 in the mPFC,
188.33 ± 19.23 in the NACs, 6.47 ± 1.97 in the NACs,
Fig. 3 Identification and quantification of SYNSERT? boutons within
limbic brain areas. a Micrograph representing double immunostaining
of SERT positive fibers (green) and the presynaptic marker synap-
tophysin (blue) in the mPFC. b Use of the masking function of Imaris
software to mask the synaptophysin labeling located outside the
SERT immunoreactive fibers. c Use of the spot detection function of
Imaris software to identify the synaptophysin puncta with a minimum
diameter of 0.4 lm. d–g Example of a 3D reconstruction of the
synaptophysin immunoreactive boutons in SERT labeled fibers in the
mPFC with Imaris software. d SERT-immunolabeled axon (green),
e synaptophysin immunolabeling (blue) inside SER- immunolabeled
fibers, f spot detection of synaptophysin puncta (blue) inside SERT-
immunolabeled fibers, g 3D reconstruction of SERT-immunoreactive
axons and the detected synoptophysin-positive boutons SYNSERT?.
h–i volumetric quantification of the density of synaptophysin
immunoreactive boutons within SERT-labeled fibers (SYNSERT?).
The results are expressed in number of boutons per 103 lm3 of tissue
(e) or per lm3 of SERT-immunoreactive fibers (f) and represented as
the mean ± SEM of n = 30 images/brain region. Scale bars, a–
c 8 lm; d–g 2 lm
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109.37 ± 13.05 in the BNST, 372.77 ± 31.16 in the BLA,
396.03 ± 36.04 in the CeA, 84.64 ± 6.55 in the HIP, and
841.88 ± 62.48 in the VTA (Fig. 7g; Table 2 and Supp
Table 7 for detailed statistical analysis). While no major
difference was observed in most of the brain regions with
respect to pre- and postsynaptic proximity, a greater pro-
portion of SYNSERT? boutons were closer to the presy-
naptic component of the putative inhibitory synapses in the
NACs (NACs pre: 61 ± 6 vs NACs post: 29 ± 3 triads/
103 lm3 of SERT? fiber, *p = 0.032, two-way ANOVA
followed by Bonferroni post hoc analysis) (Table 2 and
Supp Table 8 for statistical analysis).
Proportion of total SYNSERT1 boutons engaged
in triads
To determine the proportion of total SYNSERT? boutons
engaged in putative excitatory/inhibitory triads across the
eight brain regions (Fig. 8b–c), we used the total
SYNSERT? bouton density and the density of SYNSERT?
boutons forming synaptic triads, to calculate the density of
SYNSERT? boutons not involved in triadic contacts, here
defined as extra-triadic boutons (Fig. 8a, Supp Table 9 for
statistical analysis). We found that in the mPFC, the per-
centage of SYNSERT? boutons forming synaptic triads was
27 % (117/434), which were mainly formed via close
appositions to excitatory neurochemical synapses (100/
434 = 23 %, ****p\ 0.0001, two-way ANOVA followed
by Bonferroni post hoc analysis). In the NACs, 31 % of
SYNSERT? boutons (280/900) formed triads which were
distributed equally to excitatory (135/900 = 15 %) and
inhibitory (145/900 = 16 %) neurochemical synapses. In
the NACc, a higher, but not significantly different pro-
portion of excitatory triads were found (18/93 = 21 %), as
compared with inhibitory triads (2/93 = 3 %). Similarly,
SYNSERT? boutons forming triads in the BNST (140/
600 = 24 %) were evenly distributed onto excitatory (68/
600 = 12 %) and inhibitory (72/600 = 12 %) synapses. In
the CeA and BLA, we observed a high proportion of
SYNSERT? boutons (251/438 = 58 % and 609/999 =
61 %, respectively) that were located closer to neuro-
chemical inhibitory synapses (147/438 = 34 % and
368/999 = 37 %, *p = 0.0311 and *p = 0.0225, respec-
tively, two-way ANOVA followed by Bonferroni post hoc
analysis). The percentage of 5-HT excitatory synaptic tri-
ads was 24 % in both regions (104/438 and 241/999). In
Fig. 4 Example of the
identification of a putative
excitatory serotonergic triad.
Serial z-stack micrographs of
0.3 lm z-step showing high-
resolution images of SERT?
varicosities (green), the
presynaptic marker
synaptophysin (SYN, blue), and
the postsynaptic marker PSD95
(purple) in the hippocampus.
Synaptophysin labeling inside
the SERT? fibers (SYNSERT?
bouton, arrow) is in close
apposition (0.6 lm) to a
neurochemical excitatory
synapse, defined by the close
apposition (0.6 lm) to spot
pairs of a synaptophysin
(outside to SERT? fibers, star)
and PSD95 (arrow head). Scale
bar 1 lm
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the HIP, the proportion of boutons forming triads was 33 %
(121/365). The percentage SYNSERT? boutons in proximity
to putative excitatory or inhibitory synapses were 21 %
(75/365) and 13 % (46/365) respectively. In the VTA, the
SYNSERT? boutons were preferentially located in close
proximity to inhibitory neurochemical synapses (2291/
5202 = 44 %, ****p\ 0.0001, two-way ANOVA fol-
lowed by Bonferroni post hoc analysis), and very few
excitatory triads (4/5202\ 1 %) were observed (Fig. 8c
and Supp Table 10 for statistical analysis).
Pearson correlation analysis showed no correlation
between the ratios of excitatory/inhibitory triads along
SERT? fibers and the ratios of putative excitatory/in-
hibitory synapses throughout the eight brain regions ana-
lyzed (Pearson r = 0.5744; number of XY pairs = 8;
p = 0.1365, Supp Fig. 4), which suggests that the volu-
metric density of SYNSERT? boutons forming excitatory or
inhibitory triads is not driven by the abundance of neuro-
chemical excitatory or inhibitory synapses within each
brain region.
Discussion
In this study, we have adapted a semi-automated method
combining multi-step immunolabeling and high-resolution
confocal imaging to reconstruct in 3D a total of 195.43 mm
of SERT-immunoreactive axons and map the distribution
of synaptophysin-immunoreactive boutons forming
synaptic triads with excitatory or inhibitory neurochemical
Fig. 5 3D-reconstruction and quantification of excitatory 5-HTergic
triads throughout the limbic brain. a Micrograph representing double
immunostaining of the presynaptic marker synaptophysin (blue) and
the excitatory postsynaptic marker PSD95 (purple) in the BLA. b The
use of the spot colocalization function in Imaris to identify the
synaptophysin (blue) and PSD95 (purple) spot pairs in the vicinity of
0.6 lm, which defined neurochemical excitatory synapses. c Higher
magnification of synaptophysin (blue) and PSD95 (purple) spot pairs.
d The use of the spot detection function of Imaris software to
reconstruct the neurochemical excitatory synapses in 3D. e 3D
reconstruction of SYNSERT? boutons within SERT? fibers (green)
apposed to within 0.6 lm of the presynaptic specialization of a
neurochemical excitatory synapse (blue). f 3D reconstruction of
SYNSERT? boutons in SERT? fibers (green) orientated toward the
postsynaptic specialization of a neurochemical excitatory synapse
(purple). g Quantification of the density of putative excitatory triads.
The results are expressed as the number of putative synapses per
103 lm3 of SERT? fiber. The densities of SYNSERT? boutons
preferentially orientated towards the presynaptic (black), postsynaptic
(dark gray) or equidistant from both specializations (light gray) are
represented as the mean ± SEM of n = 30 images/brain region.
Scale bars, a, b 10 lm; c, d 1 lm; e, f 2 lm
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synapses throughout the mouse limbic brain. For the first
time, we provide a comparative volumetric quantification
of the distribution SERT-immunoreactive axons and the
density of serotonergic excitatory and inhibitory synaptic
triads within several limbic areas of the mouse brain.
Use of the serotonin transporter SERT as a marker
of serotonergic axons
Serotonin immunolabeling has been extensively used to
label serotonergic axons and quantify their densities in the
brain. However, serotonin is a neurotransmitter which can
be rapidly metabolized, and thus, the use of antibodies to
label serotonin might underestimate the density of sero-
tonin axons. Here, we choose to use an antibody against the
serotonin transporter, which has been shown to be a more
robust marker of serotonergic axons than 5-HT itself
(Nielsen et al. 2006). However, precautions should also be
considered when using SERT as a marker of 5-HT neurons
due to the subtle differences that may be detected between
SERT and 5-HT immunolabeling. During development,
some non-5-HT producing neurons in the thalamus, limbic
cortex, hypothalamus, retina and superior olivary nucleus
transiently express the SERT (Lebrand et al. 1998; Nar-
boux-Neˆme et al. 2008). In adult rats, although comparable
labeling has been observed throughout the cerebral cortex
and striatum with only minor differences in the hip-
pocampus, entorhinal cortex and the NAC core, more
pronounced differences have been detected in the caudal
part of the NAC shell (Brown and Molliver 2000). This
previous work has shown that the NAC shell is innervated
by two functionally different types of 5-HTergic axons that
either contains or lacks the SERT. Our method of labeling
of 5-HT fibers with an antibody directed against SERT may
have only uncovered a particular subset of serotonergic
axons expressing SERT in the NAC shell and is, therefore,
likely to have underestimated the density of serotonergic
axons and their triadic associations in this region. Further
work is needed to determine the distribution and proportion
of 5-HT axons lacking the SERT in the mouse NAC shell
as well as in other limbic brain regions.
Serotonergic triads, electron microscopy,
and physiology
A similar approach to the one used in our study combined
array tomography and high-resolution immunolabeling to
identify 5-HT synaptic triads in the dorsal raphe nuclei.
Both glutamatergic and GABAergic terminals converged
onto serotonergic TPH-labeled neurons to modulate of the
excitatory activity of serotonergic neurons in rats (Soiza-
Reilly et al. 2013; Soiza-Reilly and Commons 2014). We
Table 2 Density of SYNSERT?
synaptic triads
Brain region Density of SYNSERT? synaptic triads per 103 lm3 of SERT? fiber
Excitatory (mean ± SEM; % ± SEM) Inhibitory (mean ± SEM; % ± SEM)
Pre Post Equidistant Pre Post Equidistant
mPFC 72 ± 10 55 ± 8 214 ± 25 17 ± 3 7 ± 1 20 ± 4
20 ± 1 15 ± 1 65 ± 1.5 43 ± 5 17 ± 3 40 ± 3
NACs 26 ± 3 16 ± 2 117 ± 8 61 ± 6* 29 ± 3 99 ± 10
16 ± 1 10 ± 1 74 ± 2 32 ± 1 15 ± 1 53 ± 1
NACc 3.2 ± 0.7 1.3 ± 0.5 47 ± 5 2.5 ± 0.8 0.7 ± 0.5 3.3 ± 1
5 ± 1 2 ± 1 93 ± 2 50 ± 10 4 ± 3 46 ± 10
BNST 15 ± 1.5 12 ± 1.5 66 ± 5 37 ± 6 18 ± 2.5 54 ± 6
15 ± 1 12 ± 1 73 ± 2 33 ± 2 17 ± 1.4 50 ± 2
CeA 56 ± 6*** 28 ± 3 180 ± 13 95 ± 10 69 ± 6 232 ± 21
20 ± 1.5 10 ± 1 70 ± 2 23 ± 1 18 ± 1 59 ± 1
BLA 55 ± 7 40 ± 10 140 ± 10 90 ± 8 66 ± 5 217 ± 19
22 ± 1 15 ± 2 63 ± 2 24 ± 0.6 18 ± 0.5 58 ± 0.7
HIP 33 ± 4 20 ± 2.5 92 ± 7.5 17 ± 2 17 ± 2 50 ± 5
21 ± 1 14 ± 1 65 ± 1 20 ± 1 20 ± 1.5 60 ± 2
VTA 0.55 ± 0.19 0.07 ± 0.03 0.66 ± 0.15 160 ± 11 152 ± 10 529 ± 43
32 ± 6 6 ± 3 62 ± 6 19 ± 0.7 19 ± 0.7 62 ± 0.8
Data in italic are expressed as mean and SEM in % of total excitatory or inhibitory triads
* p\ 0.05; *** p\ 0.001, as compared to SYNSERT? boutons apposed to the postsynaptic component by
two-way ANOVA analysis of variance followed by Bonferroni post hoc comparisons. An overall inter-
action was observed between both factors ‘‘brain region 9 pre/post/equidistant location of triads’’, F(14,
464) = 62.87, p\ 0.0001, with a main effect of each factor ‘‘brain region’’, F(7, 232) = 75.32,
p\ 0.0001 and ‘‘pre/post/equidistant location of triads’’, F(2, 464) = 423.2, p\ 0.0001
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therefore focused on mapping SERT-immunoreactive
axons fiber density and distribution of putative serotonergic
boutons forming synaptic triads with excitatory or inhibi-
tory neurochemical synapses in mouse limbic brain regions
known to receive a high level of 5-HT synaptic input. Our
comprehensive assessment and detailed statistical analysis
of the distribution of ‘‘excitatory vs inhibitory’’ seroton-
ergic triads and their ‘‘pre- vs postsynaptic’’ location have
highlighted some specific differences in the architecture of
serotonergic triads within limbic brain areas. These data
suggest that 5-HT axons might differentially modulate
excitatory or inhibitory transmission in these brain regions,
however, further work is needed to confirm the functional
significance and ultrastructural distribution of these triads
throughout the mouse brain.
In the layer I–III of the prefrontal cortex, the most
densely 5-HT-innervated layer in the cortex (Audet et al.
1989), we showed that SYNSERT? boutons preferentially
formed triads with neurochemical excitatory synapses,
suggesting that 5-HT may have a preferential role in the
regulation of glutamate transmission in this region. In line
with this, electron microscopy studies have observed that
junctional and non-junctional appositions of 5-HT-
immunoreactive axons to non-5-HTergic axons or den-
drites engaged in asymmetrical (excitatory) synapses in a
triadic formation were frequently encountered in the upper
layers of the frontal cortex in rats (Se´gue´la et al. 1989),
suggesting both a pre- or postsynaptic control of excitatory
transmission in this brain region. Electrophysiology studies
in rats have also shown 5-HT-mediated pre- and postsy-
naptic effects in this brain region including increases both
glutamate release and the amplitude of glutamatergic
postsynaptic currents (EPSCs) (Aghajanian and Marek
1997). These interactions between 5-HT and glutamate
within functional triadic contacts could play an important
role in the etiology of psychosis and be a promising target
for the development of antipsychotics (Marek and Agha-
janian 1998) and the treatment of schizophrenia (Gonza´lez-
Maeso et al. 2008).
In the NAC core and shell, we show that SYNSERT?
boutons were equally distributed among excitatory and
inhibitory neurochemical synapses with a non-significant
preference to the formation of excitatory triads in the
NACc. Triadic associations of 5-HT- or SERT-immuno-
labelled axons to non-serotonergic axons forming both
symmetrical (inhibitory) or asymmetrical (excitatory)
Fig. 6 Example of the
identification of a putative
inhibitory serotonergic triad.
Serial z-stack micrographs of
0.3-lm z-step showing high-
resolution images of SERT?
varicosities (green), the
presynaptic marker
synaptophysin (SYN, blue), and
the postsynaptic marker
gephyrin (GEPH, purple) in the
hippocampus. Synaptophysin
labeling inside the SERT? fibers
(SYNSERT? bouton, arrow) is in
close apposition (0.6 lm) to a
neurochemical inhibitory
synapse, defined by the close
apposition (0.6 lm) spot pairs
of synaptophysin (outside to
SERT? fibers, star) and GEPH
(arrow head). Scale bar 1 lm
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synapses have been previously observed by electron
microscopy in the NAC core and shell of rats (Van
Bockstaele and Pickel 1993; Pickel and Chan 1999). The
proximity of 5-HT-positive axon terminals to GABA ter-
minals engaged in symmetrical (inhibitory) synapses
revealed by electron microscopy in rats (Van Bockstaele
et al. 1996) suggests that 5-HT could influence the release
of GABA. This is supported by functional studies showing
a modulation of GABA release in the NAC by 5-HT2C
receptors in rats (Kasper et al. 2015). Interestingly, we
found a significantly higher proportion of SYNSERT?
boutons located closer to the presynaptic component of
putative inhibitory synapses within the NAC shell, sug-
gesting that 5-HT could have a modulatory effect on
GABA release from GABAergic synapses in this area.
Furthermore, functional studies have also revealed 5-HT-
mediated control of glutamate release in rat NAC core and
shell slices via activation of presynaptic 5-HT1B receptors
(Muramatsu et al. 1998), however, we did not observe any
preferential location of SYNSERT? boutons to the pre- or
the postsynaptic component of excitatory triads. Whether
5-HTergic boutons are truly equally distributed toward the
pre- and postsynaptic components of glutamate synapses to
regulate glutamate signaling in the mouse NAC or whether
our methodology using a SERT antibody only focused on a
particular subtype of 5-HT neurons in this region remains
to be determined.
Among the brain regions analyzed, we found that the
highest proportions of SYNSERT? boutons engaged in tri-
ads were in the BLA and CeA of the amygdala, reaching 61
Fig. 7 3D-reconstruction and quantification of inhibitory 5-HTergic
triads throughout the limbic brain. a Micrograph representing a
double immunostaining of the presynaptic marker synaptophysin
(blue) and the inhibitory postsynaptic marker gephyrin (red) in the
BLA. b Use of the spot colocalization function in Imaris to identify
the synaptophysin (blue) and gephyrin (red) spot pairs in the vicinity
of 0.6 lm, which defined neurochemical inhibitory synapses.
c Higher magnification image of synaptophysin (blue) and gephyrin
(red) spot pairs. d Use of the spot detection function of Imaris
software to reconstruct the neurochemical inhibitory synapses in 3D.
e 3D reconstruction of SYNSERT? boutons within SERT? fibers
(green) apposed to within 0.6 lm presynaptic specialization of a
neurochemical inhibitory synapse (blue). f 3D reconstruction of
SYNSERT? boutons in SERT? fibers (green) orientated toward the
postsynaptic specialization of a neurochemical inhibitory synapse
(red). g Quantification of the density of putative inhibitory triads. The
results are expressed as the number of putative synapses per 103 lm3
of SERT? fiber. The density of SYNSERT? boutons preferentially
orientated toward the presynaptic (black), postsynaptic (dark gray) or
equidistant from both specializations (light gray) are represented as
the mean ± SEM of n = 30 images/brain region. Scale bars, a,
b 10 lm; c, d 1 lm; e, f 2 lm
Brain Struct Funct (2017) 222:1297–1314 1309
123
and 58 %, respectively. We observed a slightly higher
number of SYNSERT? boutons located in closer apposition
toward inhibitory neurochemical synapses than excitatory
synapses. In the BLA, serotonergic triads apposed to both
symmetrical (inhibitory) and asymmetrical (excitatory)
synapses have been identified by electron microscopy in
rats (Muller et al. 2007). We have previously shown that in
the rat BLA, interneurons contain a significantly higher
neurochemical GABAergic synapse density compared with
principal neurons (Klenowski et al. 2015). The preferential
proximity of SYNSERT? boutons to neurochemical inhibi-
tory synapses could therefore suggest that serotonergic
axons projecting to the BLA may preferentially target local
interneurons and modulate their activity. Although this
requires further investigation, previous electrophysiology
reports have demonstrated preferential 5-HT mediated
effects on interneurons in the BLA (Rainnie 1999). At a
presynaptic level, GABA release in rat BLA slices was
Fig. 8 Quantification of extra-triadic, excitatory, and inhibitory
triadic SYNSERT? boutons throughout the limbic brain. a Quantifica-
tion of extra-triadic SYNSERT? boutons. The results are expressed as
number of boutons per 103 lm3 of SERT? fiber and represented as
the mean ± SEM of n = 30 images/brain region. b Quantification of
extra-triadic, excitatory and inhibitory triadic SYNSERT? boutons.
The results are expressed as the number of boutons per 103 lm3 of
SERT? fiber. The density of extra-triadic (dark gray), excitatory
(black) or inhibitory (light gray) triadic boutons is represented as the
mean ± SEM of n = 30 images/brain region. c Proportions of triadic
vs extra-triadic boutons. The ratio of extra-triadic (dark gray),
excitatory (black), and inhibitory (light gray) triadic boutons are
represented as a percentage of the total density SYNSERT? boutons for
each brain region. *p\ 0.05; ***p\ 0.001 and ****p\ 0.0001
from two-way ANOVA analysis of variance and Bonferroni post hoc
comparison on the mean ± SEM calculated in (b)
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shown to be inhibited by 5-HT1A (Koyama et al.
1999, 2002; Kishimoto et al. 2000) and activated by
5-HT2A (Jiang et al. 2008) and 5-HT3 (Koyama et al.
2000, 2002) receptors. Combined these results are consis-
tent with 5-HT connectivity structured toward the regula-
tion of inhibitory GABAergic activity in the BLA (Muller
et al. 2007). Because the excitability of BLA principal
cells, which presumably represents a functional basis of
anxiety states, is potently controlled by local GABAergic
interneurons (Rainnie et al. 1991; Washburn and Moises
1992; Lang and Pare´ 1997, 1998), the regulation of
GABAergic synapses by 5-HT is in line with a potential
role of 5-HT signaling in the BLA in anxiety-related
behaviors (Strauss et al. 2013; Vicente and Zangrossi
2014).
The CeA consists primarily of GABAergic projection
neurons and interneurons (Sun and Cassell 1993; Veinante
and Freund-Mercier 1998) that integrate and modulate
glutamatergic inputs from the thalamus, cortex and BLA
(LeDoux 2007) to mediate behavioral and physiological
responses associated with fear/anxiety (Kalin et al. 2004;
Ciocchi et al. 2010) and various negative emotional states
including stress/anxiety following alcohol withdrawal
(Roberto et al. 2012; Gilpin et al. 2015). Our results
showing the preferential locality of SYNSERT? boutons to
inhibitory synapses in the CeA are consistent with the
contribution of 5-HT signaling in the regulation of anxiety-
related behaviors (Mo et al. 2008) being facilitated by
modulation of the local GABAergic microcircuit in the
CeA (Ciocchi et al. 2010; Jiang et al. 2014). Further
functional studies are however needed to confirm the role
of 5-HT in the regulation of local GABAergic circuitry.
In the VTA, we observed the highest density of SERT?
fibers and SYNSERT? boutons, as well as the largest aver-
age fiber diameter. This result was likely given the prox-
imity of the VTA to the raphe nucleus. Importantly, almost
half of these total boutons (44 %) were located in close
proximity to putative inhibitory synapses and a very low
number (\1 %) in the proximity of putative excitatory
synapses. Considering the large network of GABAergic
neurons in the VTA, this result was somewhat expected
and is in line with previous electron microscopy (Herve´
et al. 1987) and functional studies. For example, 5-HT1B
agonist application was shown to reduce [3H]-GABA
release (Johnson et al. 1992; Yan and Yan 2001) and
GABAB-mediated IPSCs in VTA dopamine (DA) neurons
(Cameron and Williams 1994). Furthermore, cocaine-in-
duced reductions in GABAB inhibitory postsynaptic
potentials in DA neurons of rat VTA slices were found to
be mediated by 5-HT1B receptor activation (Cameron and
Williams 1994), which, in turn, facilitates cocaine-induced
increases in DA levels in the NACc (Parsons et al. 1999;
O’Dell and Parsons 2004). Collectively, these data suggest
that 5-HT modulation of VTA signaling occurs primarily
via the regulation of local and/or non-local inhibitory
synapses. Dopaminergic neurons in the VTA that project to
the NAC to form the mesolimbic reward pathway are
sensitive to 5-HT/GABA interactions which affect the
release of DA in the NAC, notably, in response to cocaine
(Cameron and Williams 1994; O’Dell and Parsons 2004),
MDMA (Bankson and Yamamoto 2004) and alcohol
(Theile et al. 2009). Our methodology could help to iden-
tify changes in SERT? fiber density and 5-HT connectivity
contributing to the dysregulation of DAergic signaling that
is associated with the development of addictive behaviors.
Methodological considerations
Electron microscopy studies have revealed that 5-HT axons
directly contact the dendrites and the cell bodies of various
types of neurons via symmetrical or asymmetrical synap-
ses, and also form triadic contacts with dendrites or axons
that are engaged in synapses (for review, see Descarries
et al. 2010). Symmetrical and asymmetrical synapses have
been proposed to be inhibitory and excitatory, respectively;
however, specific markers for the postsynaptic component
of 5-HT symmetrical or asymmetrical synapses identified
from EM have not yet been determined. Consequently, the
quantitative distribution of these synapses cannot be con-
clusively resolved by fluorescence microscopy. Therefore,
our study focused on quantifying the density of seroton-
ergic boutons in close proximity to ‘‘conventional’’
synapses, identified using well-validated neurochemical
markers of excitatory and inhibitory pre- and postsynaptic
specializations, to estimate the density and distribution of
serotonergic excitatory/inhibitory triads throughout the
mouse limbic brain.
Interestingly, in some brain regions, including the
mPFC, NACc, HIP, and VTA, the proportion of excitatory,
inhibitory, and extra-triadic SYNSERT? boutons that we
observed were in line with the proportion of asymmetrical,
symmetrical, and extra-synaptic 5-HT boutons observed in
previous electron microscopy studies (Herve´ et al. 1987;
Se´gue´la et al. 1989; Oleskevich et al. 1991; Van Bockstaele
and Pickel 1993; Smiley and Goldman-Rakic 1996; Miner
et al. 2000). If direct asymmetrical and symmetrical
synapses made by 5-HT boutons on dendrites are presumed
to be excitatory and inhibitory, respectively, our data
suggest that the excitatory/inhibitory balance of 5-HT
bouton connectivity is a common structural feature related
to both 5-HTergic direct synapses and synaptic triads in
brain regions that we have investigated. However, addi-
tional EM studies that characterize the postsynaptic den-
sities of asymmetrical and symmetrical 5-HT synapses are
required to verify this hypothesis.
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The methodology described here is highly dependent on
the specificity of the antibodies used. Careful consideration
should be given to the choice of antibodies and the control
of the non-specific labeling of each antibody, to determine
the right antibody dilution, labeling sequence and to ensure
the best signal-to-noise ratio. Here, we used a combination
of specific, well-validated antibodies to achieve high-
quality immunolabeling and high-resolution imaging.
Future investigations implementing this methodology
should also be aware that the generation of consistent
quantitative data is highly dependent on slice preparation.
In summary, this method allows for a fast quantitative
analysis of 5-HT innervation and connectivity in the mouse
brain. The combination of this technique with other
methods, for example, with the reconstruction of neurobi-
otin-filled neurons (Fogarty et al. 2013; Klenowski et al.
2015), offers the possibility for the distribution of
5-HTergic excitatory/inhibitory triads along the dendritic
trees, axon or soma of a single intracellularly labeled
neuron to be determined in the future studies.
Conclusion
Serotonin neurons are highly plastic both during develop-
ment and in the mature brain (Azmitia 1999). Furthermore,
alterations in 5-HT signaling have been implicated in the
etiology of various neuropsychiatric disorders, including
stress, anxiety, depression, and addiction. For example,
changes in serotonin neuronal innervation and function
have been observed in rodents or monkeys following pre-
natal exposure to stress (Miyagawa et al. 2011), alcohol
(for review, see Belmer et al. 2016) or cocaine (Snyder-
Keller and Keller 1993). Early life or adulthood exposure
to stress (Kuramochi and Nakamura 2009; Xue et al. 2013;
Ohta et al. 2014), MDMA (Hatzidimitriou et al. 1999) or
selective serotonin reuptake inhibitors (Zhou et al. 2006)
also facilitate changes in 5-HTergic signaling. This high-
throughput screening method provides a valuable tool for
determining how 5-HTergic neuron plasticity is modulated
following chronic exposure to anxious stimuli, stressors or
drugs of abuse which can be investigated using behavioral
paradigms in rodents. Furthermore, given the fact that
transgenic mouse lines are now available to identify axonal
projections of many neuronal types, such as cholinergic
(Tallini et al. 2006), dopaminergic (Zhou et al. 2009), and
noradrenergic (Kanazawa et al. 2010) neurons, this method
could be adapted to map the changes in the plasticity of
several neuronal pathways. A detailed analysis of the
functional connectivity of these neuronal populations will
help to provide a greater understanding of how brain
connectivity is altered in numerous mental and psychiatric
disorders.
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